Blocking Sema7A in CIA exerted favorable therapeutic effects and achieved a dramatic arrest in disease progression, as confirmed by the clinical, histopathological, and immunological manifestations of arthritis. This evidence concerns the gene SEMA7A and arthritic joint disease.